Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MannKind
MannKind
2 Healthcare Upgrades Investors Should Consider
Seeking Alpha
Sat, 08/11/12 - 12:16 pm
MannKind
Sanofi
3 Reasons This Speculative Bio-Pharma Is A Winner
Seeking Alpha
Sat, 08/11/12 - 11:30 am
MannKind
Afrezza
diabetes
type 1 diabetes
type 2 diabetes
MannKind Reports Narrower 2Q Loss
Yahoo/Zacks
Thu, 08/9/12 - 11:31 am
MannKind
earnings
MannKind 2Q loss narrows on year-ago payment
Yahoo/AP
Tue, 08/7/12 - 12:01 pm
MannKind
earnings
Is This the End of MannKind?
Motley Fool
Sun, 07/29/12 - 12:12 pm
MannKind
Obesity, Heart Disease And Diabetes - A Biotech Triumvirate To Profit From Healthcare Mega-Trends In The Medium Term
Seeking Alpha
Wed, 07/25/12 - 09:38 am
obesity
heart disease
diabetes
Amarin
MannKind
Arena Pharmaceuticals
Top 20 biotech licensing deals in H1 2012
Fierce Biotech
Wed, 07/11/12 - 12:47 pm
Xenon
Virobay
Tolero Pharmaceuticals
Threshold Pharmaceuticals
Novartis
Merck KGaA
Merck
MannKind
licensing
Janssen
Isis Pharmaceuticals
Ironwood
Inhibrx Thrombogenics
GSK
Genmab
Genentech
Galapagos
Forma Therapeutics
Endocyte
Endo
Enanta
Celgene
Bristol-Myers Squibb
Boehringer Ingelheim
Bionomics
Biogen Idec
BioDelivery Sciences
AstraZeneca
Angiochem
AC Immune
Abbott Laboratories
LEO Pharma
Are These Insiders Telling You to Buy?
Motley Fool
Sat, 07/7/12 - 11:56 am
MannKind
Synta Pharmaceuticals
MannKind Fights On With Its Diabetes Game-Changer Afrezza
Seeking Alpha
Fri, 07/6/12 - 10:59 am
diabetes
Afrezza
inhaled insulin
MannKind
Buy, Sell, or Hold: MannKind
Motley Fool
Sat, 06/30/12 - 03:44 pm
MannKind
Pre-Clinical Data Demonstrates Promising Potential of MannKind’s IRE1α Inhibitor to Treat Multiple Myeloma
Yahoo
Thu, 05/31/12 - 06:26 pm
MannKind
IRE1α inhibitor
MKC-3946
Multiple Myeloma
MannKind Narrows Loss
Yahoo/Zacks
Thu, 05/10/12 - 12:15 pm
earnings
MannKind
MannKind Rents Out a Drug Program
Motley Fool
Tue, 05/1/12 - 12:37 pm
MannKind
Tolero
Btk inhibitors
MannKind says it could get $130M and royalties after licensing drug candidates to Tolero
Yahoo/AP
Mon, 04/30/12 - 11:20 am
MannKind
Tolero
MannKind: Will The Good News Ever Come?
Seeking Alpha
Wed, 04/25/12 - 10:25 am
MannKind
Afrezza
inhaled insulin
diabetes
MannKind Narrows Loss
Yahoo/Zacks
Thu, 02/23/12 - 11:59 am
earnings
MannKind
Easing The Pain: Why Investment In Bio-Pharma Is A Worthy Cause
Seeking Alpha
Wed, 02/1/12 - 12:19 pm
Bristol-Myers Squibb
Ariad Pharmaceuticals
Inhibitex
Vertex Pharmaceuticals
Spectrum Pharmaceuticals
MannKind
Another Small Step Back For Mannkind
Seeking Alpha
Wed, 02/1/12 - 09:03 am
MannKind
Jentadueto
diabetes
Afrezza
4 Biotech Stocks To Consider Buying, 2 To Sell In 2012
Seeking Alpha
Sat, 01/28/12 - 12:18 pm
Roche Holding AG
Aeterna Zentaris
Gilead Sciences
Spectrum Pharmaceuticals
Arena Pharmaceuticals
MannKind
Biopharma Stocks To Watch This Week
Seeking Alpha
Thu, 01/19/12 - 11:12 am
BioDelivery Sciences
Biovest International
Celldex
MannKind
NovaBay Pharmaceuticals
Keryx
ImmunoCellular
Cel-Sci
Dendreon
Generex
Human Genome Sciences
Pages
« first
‹ previous
…
14
15
16
17
18
19
20
21
22
…
next ›
last »